New drug shows promise in Parkinson`s disease
Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), protected neurobehavioral function in mice with Parkinson`s Disease symptoms by preventing deficits in motor coordination, according to a study.
In a specific type of transgenic mouse called LRRK2R1441G, the animals lose coordinated movements and develop Parkinson`s-type symptoms by ten months of age.
In this study, the researchers treated those mice with diapocynin starting at 12 weeks. That treatment prevented the expected deficits in motor coordination.